FXYD6P3

Across TCGA pan-cancer cohorts, FXYD6P3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated FXYD6P3 data layer compared with 9 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher FXYD6P3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FXYD6P3 expression acts as an unfavorable survival marker.

COAD and LUAD are the cancer types where FXYD6P3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.234	0.809	.002	24	view →
LUAD	OS	Median	All	0.079	0.788	<.001	20	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

FXYD6P3–COAD (OS)

Open the COAD breakdown →